89 related articles for article (PubMed ID: 10394132)
1. Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients.
Kim CW; Choi SH; Chung EJ; Lee MJ; Byun EK; Ryu MH; Bang YJ
Pathobiology; 1999; 67(3):123-8. PubMed ID: 10394132
[TBL] [Abstract][Full Text] [Related]
2. Alteration of signal-transducing molecules in tumor-infiltrating lymphocytes and peripheral blood T lymphocytes from human colorectal carcinoma patients.
Choi SH; Chung EJ; Whang DY; Lee SS; Jang YS; Kim CW
Cancer Immunol Immunother; 1998 Feb; 45(6):299-305. PubMed ID: 9490199
[TBL] [Abstract][Full Text] [Related]
3. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus.
Blasini AM; Brundula V; Paris M; Rivas L; Salazar S; Stekman IL; Rodriguez MA
J Autoimmun; 1998 Oct; 11(5):387-93. PubMed ID: 9802921
[TBL] [Abstract][Full Text] [Related]
5. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
Matsuda M; Petersson M; Lenkei R; Taupin JL; Magnusson I; Mellstedt H; Anderson P; Kiessling R
Int J Cancer; 1995 Jun; 61(6):765-72. PubMed ID: 7790109
[TBL] [Abstract][Full Text] [Related]
7. T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.
Levey DL; Srivastava PK
J Exp Med; 1995 Oct; 182(4):1029-36. PubMed ID: 7561676
[TBL] [Abstract][Full Text] [Related]
8. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions.
Maccalli C; Pisarra P; Vegetti C; Sensi M; Parmiani G; Anichini A
J Immunol; 1999 Dec; 163(12):6912-23. PubMed ID: 10586094
[TBL] [Abstract][Full Text] [Related]
9. Distribution of T-cell signalling molecules in human myeloma.
Bianchi A; Mariani S; Beggiato E; Borrione P; Peola S; Boccadoro M; Pileri A; Massaia M
Br J Haematol; 1997 Jun; 97(4):815-20. PubMed ID: 9217182
[TBL] [Abstract][Full Text] [Related]
10. Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors.
Salvadori S; Gansbacher B; Pizzimenti AM; Zier KS
J Immunol; 1994 Dec; 153(11):5176-82. PubMed ID: 7963575
[TBL] [Abstract][Full Text] [Related]
11. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.
Mizoguchi H; O'Shea JJ; Longo DL; Loeffler CM; McVicar DW; Ochoa AC
Science; 1992 Dec; 258(5089):1795-8. PubMed ID: 1465616
[TBL] [Abstract][Full Text] [Related]
12. Alterations in T cell receptor and signal transduction molecules in melanoma patients.
Zea AH; Curti BD; Longo DL; Alvord WG; Strobl SL; Mizoguchi H; Creekmore SP; O'Shea JJ; Powers GC; Urba WJ
Clin Cancer Res; 1995 Nov; 1(11):1327-35. PubMed ID: 9815928
[TBL] [Abstract][Full Text] [Related]
13. Expression of signal transducing T-cell receptor zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer.
Kono K; Ichihara F; Iizuka H; Sekikawa T; Matsumoto Y
Int J Cancer; 1998 Oct; 78(3):301-5. PubMed ID: 9766562
[TBL] [Abstract][Full Text] [Related]
14. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
15. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL
Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes.
Riccobon A; Gunelli R; Ridolfi R; De Paola F; Flamini E; Fiori M; Saltutti C; Petrini M; Fiammenghi L; Stefanelli M; Granato AM; Cuzzocrea DE; Amadori D
Cancer Invest; 2004; 22(6):871-7. PubMed ID: 15641485
[TBL] [Abstract][Full Text] [Related]
17. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-zeta, and ZAP-70.
Stone JD; Conroy LA; Byth KF; Hederer RA; Howlett S; Takemoto Y; Holmes N; Alexander DR
J Immunol; 1997 Jun; 158(12):5773-82. PubMed ID: 9190928
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract][Full Text] [Related]
19. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.
Rahmouni S; Vang T; Alonso A; Williams S; van Stipdonk M; Soncini C; Moutschen M; Schoenberger SP; Mustelin T
Mol Cell Biol; 2005 Mar; 25(6):2227-41. PubMed ID: 15743820
[TBL] [Abstract][Full Text] [Related]
20. Lipid rafts: resolution of the "fyn problem"?
Filipp D; Julius M
Mol Immunol; 2004 Jul; 41(6-7):645-56. PubMed ID: 15220001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
